Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco, Carolina Ortiz‐Lopez, Beverly Orsak et al. · Hepatology · 2011
UNLABELLED: The role of adipose tissue insulin resistance in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) remains unclear. To evaluate this, we measured in 207 patients with NAFLD (age = 51 ± 1, body mass index = 34.1 ± 0.3 kg/m(2) ) and 22 controls without NAFLD (no NAFLD) adipose tissue insulin resistance by means of a validated index (Adipo-IR(i) = plasma free fatty acids [FFA] x insulin [FPI] concentration) and as the suppression of plasma FFA during an oral glucose tolerance test and by a low-dose insulin infusion. We also explored the relationship between adipose tissue insulin resistance with metabolic and histological parameters by dividing them based on quartiles of adipose tissue insulin resistance (Adipo-IR(i) quartiles: Q1 = more sensitive; Q4 = more insulin resistant). Hepatic insulin resistance, measured as an index derived from endogenous glucose production x FPI (HIRi), and muscle insulin sensitivity, were assessed during a euglycemic insulin clamp with 3-[(3) H] glucose. Liver fat was measured by magnetic resonance imaging and spectroscopy, and a liver biopsy was performed to assess liver histology. Compared to patients without steatosis, patients with NAFLD were insulin resistant at the level of adipose tissue, liver, and skeletal muscle and had higher plasma aspartate aminotransferase and alanine aminotransferase, triglycerides, and lower high-density lipoprotein cholesterol and adiponectin levels (all P < 0.01). Metabolic parameters, hepatic insulin resistance, and liver fibrosis (but not necroinflammation) deteriorated as quartiles of adipose tissue insulin resistance worsened (all P < 0.01). CONCLUSION: Adipose tissue insulin resistance plays a key role in the development of metabolic and histological abnormalities of obese patients with NAFLD. Treatment strategies targeting adipose tissue insulin resistance (e.g., weight loss and thiazolidinediones) may be of value in this population.
Cited by 459 works. doi:10.1002/hep.25539 Open-access PDF
Authors
- Romina Lomonaco
- Carolina Ortiz‐Lopez
- Beverly Orsak
- Amy Webb
- Jean Hardies
- Celia Darland
- Joan Finch
- Amalia Gastaldelli
- Stephen A. Harrison
- Fermin O. Tio
- Kenneth J. Cusi
References
- Glucose clamp technique: a method for quantifying insulin secretion and resistance.
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- Nonalcoholic Fatty Liver Disease
- Inflammation and insulin resistance
- How Useful Is Body Mass Index for Comparison of Body Fatness across Age, Sex, and Ethnic Groups?
- Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
- A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
- Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus
- Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical Implications